New Ray Medicine International Holding Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was HKD 214.491 million compared to HKD 69.470 million a year ago. Net income was HKD 1.133 million compared to net loss of HKD 36.434 million a year ago. Basic earnings per share from continuing operations was 0.07 HK cents compared to basic loss per share from continuing operations of 2.18 HK cents a year ago.